The endometrial ablation devices market studied was projected to grow with a CAGR of 5.2% over the forecast period. The major factor attributing to the growth of the market is the increase in the prevalence of gynecological disorders like cervical cancer, menorrhagia, abnormal vaginal bleeding, and POCD or polycystic ovarian disease in women. According to World Health Organisation, cervical cancer is the fourth most frequent cancer in women with an projected 570,000 new cases in 2018 representing 6.6% of all female cancers. Approximately 90% of deaths from cervical cancer occurred in low- and middle-income countries. Furthermore, growing demand for minimally invasive surgical procedures are expected to propel the overall growth of the market. However, stringent regulatory policies constraints the market growth.
Key Market Trends
Radiofrequency Endometrial Ablation Devices Segment is Dominating the Endometrial Ablation Devices Market .
The largest share of the segment is accounted to the factors such as high safety & fast recovery, increasing awareness related to this technique in developing countries, and high preference from several medical practitioners. Apart from the advantages of the devices the factors driving the segment growth are increasing prevalence of cervical cancer, menorrhagia and other gynecology disorders. According to Institute for Health Metrics and Evaluation, the number of cases of polycystic ovary syndrome were 2,128,998, globally or the year 2017. The large number of patients and increasing awareness of the devices and treatment is propelling the segment growth.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall Market, throughout the forecast period. The endometrial ablation devices market in this region witnessed rapid technological advancements. Escalating cases of gynaecological disorders, rising healthcare infrastructure, and strong establishment of major market players to offer innovative endometrial ablation devices are accountable for promoting the endometrial ablation devices market in this region. According to U.S. Department of Health and Human Services, 11% of women in the United States, have endometriosis, which results in inflammation, as the tissue responds to the monthly fluctuations of a woman's menstrual cycle. As per the statistics, the large patient pool and rising disposable incomes in the region is fuelling the market growth.
The Endometrial Ablation Devices Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Boston Scientific Corporation, Cooper Surgical, Medtronic, Johnson & Johnson, Olympus Corporation, Richard Wolf GmbH, Minerva Surgical, Inc., AngioDynamics, Hologic, Inc.
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
1.2 Study Assumptions
1.3 Scope of the Study
4.2 Market Drivers
4.2.1 Rising Number of Various Gynecological Disorders
4.2.2 Growing Demand for Minimally Invasive Surgical Procedures
4.3 Market Restraints
4.3.1 Unfavourable Regulatory Framework
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1.1 Hysteroscopy devices
5.1.2 Thermal balloon ablators
5.1.3 Radiofrequency endometrial ablation devices
5.1.4 Hydrothermal ablators
5.1.5 Electrical ablators
5.2 By End-User
5.2.1 Ambulatory surgical centers
5.3.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle-East and Africa
5.3.5 South America
220.127.116.11 Rest of South America
6.1.1 Boston Scientific Corporation
6.1.2 Cooper Surgical
6.1.3 Medtronic Plc
6.1.4 Johnson & Johnson
6.1.5 Olympus Corporation
6.1.6 Richard Wolf GmbH
6.1.7 Minerva Surgical, Inc.
6.1.9 Hologic, Inc.
A selection of companies mentioned in this report includes:
- Boston Scientific Corporation
- Cooper Surgical
- Medtronic Plc
- Johnson & Johnson
- Olympus Corporation
- Richard Wolf GmbH
- Minerva Surgical, Inc.
- Hologic, Inc.